Study S002085

The Comparative Effectiveness of Step-down Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide: A Randomized Controlled Trial (GLP1 Transition Trial)

ClinicalTrials.gov record

Registration

Registration: NCT06605703
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: COMPLETED
Enrollment: 226
Start: 2024-09-18
Primary completion: 2026-02-05
Lead sponsor: WW International Inc
Conditions: Obesity; Overweight
Interventions: BEHAVIORAL:WW Clinic; DRUG:Bupropion-Naltrexone; DRUG:Bupropion-Naltrexone-Metformin
Results posted: FALSE

Registered primary outcomes

Percent body weight change at 12 weeks [Baseline, 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.